Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer. [electronic resource]
Producer: 20001207Description: 1128-35 p. digitalISSN:- 0007-0920
- Adult
- Aged
- Alopecia -- chemically induced
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carboplatin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cisplatin -- administration & dosage
- Dose-Response Relationship, Drug
- Female
- Humans
- Ifosfamide -- administration & dosage
- Leukopenia -- chemically induced
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mitomycin -- administration & dosage
- Multivariate Analysis
- Neoplasm Staging
- Survival Analysis
- Survival Rate
- Thrombocytopenia -- chemically induced
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.